Apoptotic index, Fas and bcl-2 in initial and relapsed childhood acute lymphoblastic leukaemia

Apoptosis

Volumn 2, Issue 4, 1997, Pages 377-383

  Stammler, G ^a   Sauerbrey, A ^b   Zintl, F ^b   Volm, M ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Acute lymphoblastic leukaemia; Apoptosis; Bcl 2; Fas

Indexed keywords

EID: 2342651010     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026405707823     Document Type: Article

References (32)

1. Desoize B. Anticancer drug resistance and inhibition of apoptosis. Anticancer Res 1994; 14: 2291-2294.
2. Bhalla K, Ibrado AM, Tourkina E, et al. High dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells. Blood 1993; 82: 3133-3140.
3. Bhalla K, Ibrado AM, Tourkina E, Tang C, Mahoney ME, Huang Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia. Leukemia 1993; 7: 563-568.
4. Gorczyca W, Bigman K, Mittelman A, et al. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 1993; 7: 659-670.
5. Lotem J, Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 1992; 80: 1750-1757.
6. Sen S, D'Incalci M. Apoptosis. Biochemical events and relevance to cancer chemotherapy. FEBS-Lett 1992; 307: 122-127.
7. Gestblom C, Hoehner JC, Pahlman S. Proliferation and apoptosis in neuroblastoma: Subdividing the mitosis karyorrhexis index. Eur J Cancer 1995; 31: 458-463.
8. Törmänen U, Eerola AK, Rainio P, et al. Enhanced apop-tosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res 1995; 55: 5595-5602.
9. Lipponen P, Aaltomaa S, Kosma VM, Syrjänen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994; 30: 2068-2073.
10. Friesen C, Herr J, Krammer PH, Debatin KM. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med 1996; 2: 574-577.
11. Suda T, Takahashi T, Goldstein P, Nagata S. Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
12. Debatin KM, Goldman CK, Waldmann TA, Krammer PH. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 1993; 81: 2972-2977.
13. Mapara MY, Bargou R, Zugck C, et al. APO-1 mediated apoptosis or proliferation in human B lymphocytic leukemia: correlation with bcl-2 expression. Eur J Immunol 1993; 23: 702-708.
14. Panayiotidis P, Ganeshaguru K, Foroni L, Hoffbrand AV. Expression and function of the Fas antigen in B chronic lymphocyctic leukemia and hairy cell leukemia. Leukemia 1995; 9: 1227-1232.
15. Min YH, Lee S, Lee JW, Chong SY, Hahn JS, Ko YW. Expression of Fas antigen in acute myeloid leukaemia is associated with therapeutic response to chemotherapy. Br J Haematol 1996; 93: 928-930.
16. Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
17. Alnemri ES, Fernandes TF, Haldar S, Croce CM, Litwack G. Involvement of Bcl-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res 1992; 52: 491-495.
18. Campos L, Sabido O, Sebban C, et al. Expression of Bcl-2 protooncogene in adult acute lymophoblastic leukemia. Leukemia 1996; 10: 434-438.
19. Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G. Bcl-2 protein expression in normal bone marrow precursors and in acute myelogenous leukemia. Leukemia 1995; 9: 1191-1198.
20. Keith FJ, Bradbury DA, Zhu YM, Russell NH. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C. Leukemia 1995; 9: 131-138.
21. Bennett JM, Catowsky D, Daniel MT, et al. Proposal for the classification of the acute leukemias; French American British (FAB) cooperative group. Br J Haematol 1976; 33: 451-458.
22. Zintl F, Malke H, Reimann M, et al. Results with randomized BFM adopted studies for ALL therapy in childhood in East German countries. In: Büchner T, Schellong G, Hiddemann W, Urbanitz J, Ritter J, eds. Acute Leukemias. IV: Prognostic Factors. Berlin, Germany: Springer Verlag, 1993: 179-186.
23. Riehm H, Ebel W, Feickert HJ, Reiter A. Acute lymphoblastic leukemia. In: Vouté PA, Barrett A, Lemerle J, eds. Cancer in Children. Berlin, Germany: Springer Verlag, 1992: 85-106.
24. Stammler G, Sauerbrey A, Volm M. Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia. Cancer Lett 1995; 89: 129-135.
25. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986; 83: 5214-5218.
26. Leoncini L, Del Vecchio MT, Spina D, et al. Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern. Int J Cancer 1995; 61: 826-831.
27. Frankfurt OS, Byrnes JJ, Seckinger D, Sugarbaker EV. Apoptosis (programmed cell death) and the evaluation of chemosensitivity in chronic lymphocytic leukemia and lymphoma. Oncol Res 1993; 5: 37-42.
28. Lipponen PK, Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Path 1994; 173: 333-339.
29. Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995; 37: 1-9.
30. Vesalainen S, Lipponen P, Talja M, Syrjänen K. Histological grade, perineural infiltration, tumor infiltrating lymphocytes and apoptosis as determinants at long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994; 30: 1797-1803.
31. Debatin KM. Apoptoseinduktion in lymphatischen Leukämien: molekulare Grundlagen und klinische Perspektiven. Onkologie 1995; 18: 11-15.
32. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM. Regulation of apoptosis in the immune system. Curr Opinion Immunol 1994; 6: 279-289.